Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) — SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotechnology company, today offers an in-depth discussion on the company’s medical devices.

SPO Global Inc.’s medical devices include low-frequency therapy instruments and intelligent Chinese medicine decoction machines, both of which contributed to the company’s revenue growth.

The company’s new low-temperature small molecule lossless decoction machine combines ultrasonic negative pressure with intelligent decoction technology, low-temperature ultrasonic cold extraction and traditional heating technology.

These machines prove to be extremely advantageous, increasing the extraction efficiency by 2-60 times, making the small molecule Chinese medicine soup more conducive to absorption, improving the drug effect, shortening the extraction time , reducing energy consumption, automating the whole process, and making liquid medicine convenient to carry and store for up to 70 days. These machines are patented in China and customers include Chinese medical clinics, facilities and hospitals.

The company’s new low-frequency electrotherapy instrument uses low-frequency pulsed current below 1,000 Hz to treat disease. Electrical stimulation can destroy the state of polarization of the membrane and cause excitation of nerves and muscles. The frequency of 400Hz, nerve impulses and specific impulse width of 140US and sawtooth waveform is the best combination, which perfectly matches the bioelectric field of the human body in all tissue layers. It can more effectively stimulate the repair of injured nerves and the rehabilitation of sports injuries. Customers of this device include traditional Chinese medicine hospitals in Shandong.

In addition, the company is extremely satisfied that the center of Jinan has been developed and the infrastructure has been completed.

“We look forward to the completion of our projects in Shandong, Qingdao and elsewhere. We will continue to update our shareholders on our progress and endeavor to share some photos of our work, once the ongoing blockages in China have been resolved. up,” Fengyou Lu said.

We encourage our shareholders to visit our corporate Twitter account for more updates: https://twitter.com/spo_global

About SPO Global Inc. (OTC Pink: SPOM): SPO Global Inc. recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in Pharmaceutical Valley Industrial Park of Jinan High Tech Zone. Its main business scope includes biomedical R&D, development and sales of medical information software, introduction of high medical technology, production and sales of high quality medical consumables, health care products, medicines, the agency and the sale of consumables for medical equipment.

Company Disclaimer: As a publicly traded company, pursuant to federal and state securities law guidelines, SPO Global, Inc. cannot rely on safe harbor provisions such as ‘identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, potential investors and the general public by alerting them to the risks and the uncertainties associated with any investment, and the need to carry out their own due diligence and evaluation.

Forward-Looking Statements: This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are therefore forward-looking. Forward-looking statements include all statements that are not statements of historical fact regarding the current intention, belief or expectations of the Company, its directors or its officers. Investors are cautioned that these forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those set forth in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances generally, including the ability to pursue and manage its growth. , competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission.

Company Contact: fengyoulu@gmail.com

Source: SPO Global Inc.